Drew Dennison
Directeur/Membre du Conseil chez Sharpen Technologies, Inc.
Profil
Drew Oconnor Dennison is currently the Director at Sharpen Technologies, Inc., the Managing Director at Lightchain Capital LLC, the Director at NextRNA Therapeutics, Inc., and the Director at AI Proteins, Inc. Previously, he held positions as the Director at Arch Oncology, Inc., the Director at Fintech Studios, Inc., the Chief Accounting Officer at Scottrade, Inc., and the Chief Operating & Financial Officer at Scottrade Financial Services, Inc. Mr. Dennison obtained his undergraduate degree from the University of Iowa.
Postes actifs de Drew Dennison
| Sociétés | Poste | Début |
|---|---|---|
Sharpen Technologies, Inc.
 Sharpen Technologies, Inc. Packaged SoftwareTechnology Services Sharpen Technologies, Inc. develops and sells multifaceted contact-center-management software. It offers sales acceleration, contact center, unified communications, integration services, reporting and analytics, and collaborative coaching. The company was founded by Cameron Weeks and Bracken Fields in 2007 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Directeur/Membre du Conseil | 01/03/2021 |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Directeur/Membre du Conseil | - |
Lightchain Capital LLC
 Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Private Equity Investor | - |
Anciens postes connus de Drew Dennison
| Sociétés | Poste | Fin |
|---|---|---|
Scottrade Financial Services, Inc.
 Scottrade Financial Services, Inc. Investment Banks/BrokersFinance Scottrade Financial Services, Inc. provides brokerage services. It offers investment products, online trading platforms, and market research tools to help self-directed investors make their own investing decisions. The company was founded by Rodger O. Riney on March 17, 2009 and is headquartered in St. Louis, MO. | Directeur Financier/CFO | 01/09/2017 |
Scottrade, Inc.
 Scottrade, Inc. Investment Banks/BrokersFinance Scottrade, Inc. provides brokerage services. It offers investment products, online brokerage, online trading platforms, and market research tools. The company was founded by Rodger Riney in 1980 and is headquartered in St. Louis, MO. | Comptroller/Controller/Auditor | 18/07/2012 |
Fintech Studios, Inc.
 Fintech Studios, Inc. Information Technology ServicesTechnology Services Fintech Studios, Inc. provides cloud-based network of curated, disruptive FinTech apps, and big-data financial analytic products. curated fintech apps, investment research and big-data analytic services. It offers brokerage, trading, wealth management, banking and asset management, capital markets application, research, news, and financial analytics. The company was founded by Jim Tousignant and Andrew Haines in 2014 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Directeur/Membre du Conseil | - |
Formation de Drew Dennison
| University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Scottrade Financial Services, Inc.
Scottrade Financial Services, Inc. Investment Banks/BrokersFinance Scottrade Financial Services, Inc. provides brokerage services. It offers investment products, online trading platforms, and market research tools to help self-directed investors make their own investing decisions. The company was founded by Rodger O. Riney on March 17, 2009 and is headquartered in St. Louis, MO. | Finance |
Scottrade, Inc.
Scottrade, Inc. Investment Banks/BrokersFinance Scottrade, Inc. provides brokerage services. It offers investment products, online brokerage, online trading platforms, and market research tools. The company was founded by Rodger Riney in 1980 and is headquartered in St. Louis, MO. | Finance |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
Fintech Studios, Inc.
Fintech Studios, Inc. Information Technology ServicesTechnology Services Fintech Studios, Inc. provides cloud-based network of curated, disruptive FinTech apps, and big-data financial analytic products. curated fintech apps, investment research and big-data analytic services. It offers brokerage, trading, wealth management, banking and asset management, capital markets application, research, news, and financial analytics. The company was founded by Jim Tousignant and Andrew Haines in 2014 and is headquartered in New York, NY. | Technology Services |
Sharpen Technologies, Inc.
Sharpen Technologies, Inc. Packaged SoftwareTechnology Services Sharpen Technologies, Inc. develops and sells multifaceted contact-center-management software. It offers sales acceleration, contact center, unified communications, integration services, reporting and analytics, and collaborative coaching. The company was founded by Cameron Weeks and Bracken Fields in 2007 and is headquartered in Indianapolis, IN. | Technology Services |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Health Technology |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Health Technology |
Lightchain Capital LLC
Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Technology Services |
